EUVIMEDEUVIMED entdecken
Open Access

A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibitors

Rong Fu, Chunbin Wang, Tongjin Yin, Xuyao Zhang, Ying Xu, Yue Shi, Jing Xu, Wei Zhang, Zhe Ding

International Journal of Molecular Medicine · 2025

DOI: 10.3892/ijmm.2025.5507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2025. Verfasst von Rong Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People's Hospital, Yancheng, Jiangsu 22400…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Autophagy, Cell Adhesion Molecules, Immunoconjugates. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody‑drug conjugates (ADCs) are rapidly advancing the treatment of solid tumors, and Nectin‑4‑targeted ADCs have been approved by the FDA to treat certain cancers. Although Nectin‑4 is overexpressed in the tissues of patients with pancreatic cancer, whether Nectin‑4‑targeted ADCs can effectively treat pancreatic cancer remains unclear. The present study evaluated the therapeutic effects and mechanisms of Nectin‑4‑targeted ADCs in pancreatic cancer. A Nectin‑4‑directed ADC was chosen, Nectin‑4‑MMAE, which triggered apoptosis and induced cell death in the Nectin‑4‑positive pancreatic cancer cell lines BxPC‑3 and YAPC. Nectin‑4‑MMAE also induced autophagy in BxPC‑3 and YAPC cells by inactivating the AKT/mTOR pathway. The entire autophagy process was observed by electron microscopy and laser confocal microscopy. The autophagy inhibitors LY294002 and chloroquine significantly increased the lethal effects of Nectin‑4‑MMAE on BxPC‑3 and YAPC cells by inducing apoptosis. In the xenograft tumor model, Nectin‑4‑MMAE alone elicited potent antitumor effects. When Nectin‑4‑MMAE was combined with autophagy inhibitors, the tumor burden of mice was decreased compared with treatment with either drug alone. The present study confirmed the potent therapeutic effects of Nectin‑4‑MMAE against pancreatic cancer, and its unique antitumor mechanism provides new approaches to treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsAutophagyCell Adhesion MoleculesImmunoconjugatesHumansAnimalsCell Line, TumorMiceXenograft Model Antitumor AssaysApoptosisMice, NudeMice, Inbred BALB CFemaleMaleSignal TransductionNectins

Stichwörter der Autor:innen

Nectin‑4‑MMAEantibody‑drug conjugateapoptosisautophagycombination therapypancreatic cancer

Substanzen

NECTIN4 protein, humanCell Adhesion MoleculesImmunoconjugatesNectins

Autor:innen und Institutionen

  • Department of Pharmacy, Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People's Hospital, Yancheng, Jiangsu 224008, P.R. China.
  • Department of Oncology, Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People's Hospital, Yancheng, Jiangsu 224008, P.R. China.
  • Department of Pediatrics, Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng Third People's Hospital, Yancheng, Jiangsu 224008, P.R. China.
  • Department of Biological Medicines and Shanghai Engineering Research Center of Immunotherapeutic, Fudan University School of Pharmacy, Shanghai 201203, P.R. China.

Zitieren

APA

Fu, R., Wang, C., Yin, T., Zhang, X., Xu, Y., Shi, Y., Xu, J., Zhang, W., & Ding, Z. (2025). A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibitors. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2025.5507

Vancouver

Fu R, Wang C, Yin T, Zhang X, Xu Y, Shi Y, et al. A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibitors. International Journal of Molecular Medicine. 2025. doi:10.3892/ijmm.2025.5507

BibTeX
@article{Fu2025,
  author = {Fu, Rong and Wang, Chunbin and Yin, Tongjin and Zhang, Xuyao and Xu, Ying and Shi, Yue and Xu, Jing and Zhang, Wei and Ding, Zhe},
  title = {A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibitors},
  journal = {International Journal of Molecular Medicine},
  year = {2025},
  doi = {10.3892/ijmm.2025.5507}
}
Kostenlos starten →